The impact of impaired macrophage functions in cystic fibrosis disease progression

被引:60
|
作者
Leveque, Manuella [1 ,2 ]
Le Trionnaire, Sophie [1 ,2 ]
Del Porto, Paola [3 ]
Martin-Chouly, Corinne [1 ,2 ]
机构
[1] Univ Rennes 1, Struct Federat Rech Biosit, F-35043 Rennes, France
[2] INSERM, U1085, Team Stress Membrane & Signalling, Res Inst Environm & Occupationnal Hlth IRSET, F-35043 Rennes, France
[3] Sapienza Univ, Dept Biol & Biotechnol Charles Darwin, Rome, Italy
关键词
Cystic fibrosis; Macrophage; Inflammation; Lipid homeostasis; Phagocytosis; TRANSMEMBRANE CONDUCTANCE REGULATOR; BURKHOLDERIA-CENOCEPACIA; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY RESPONSES; ALVEOLAR MACROPHAGES; NONOPSONIC BINDING; IMMUNE-RESPONSES; GENE-EXPRESSION; HOST-DEFENSE; RECEPTOR;
D O I
10.1016/j.jcf.2016.10.011
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The underlying cause of morbidity in cystic fibrosis (CF) is the decline in lung function, which results in part from chronic inflammation. Inflammation and infection occur early in infancy in CF and the role of innate immune defense in CF has been highlighted in the last years. Once thought simply to be consumers of bacteria, macrophages have emerged as highly sensitive immune cells that are located at the balance point between inflammation and resolution of this inflammation in CF pathophysiology. In order to assess the potential role of macrophage in CF, we review the evidence that: (1) CF macrophage has a dysregulated inflammatory phenotype; (2) CF macrophage presents altered phagocytosis capacity and bacterial killing; and (3) lipid disorders in CF macrophage affect its function. These alterations of macrophage weaken innate defense of CF patients and may be involved in CF disease progression and lung damage. (C) 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:443 / 453
页数:11
相关论文
共 50 条
  • [1] Predicting disease progression in cystic fibrosis
    Breuer, Oded
    Caudri, Daan
    Stick, Stephen
    Turkovic, Lidija
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (11) : 905 - 917
  • [2] The Dynamics of Disease Progression in Cystic Fibrosis
    Adler, Frederick R.
    Liou, Theodore G.
    PLOS ONE, 2016, 11 (06):
  • [3] Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
    Meoli, Aniello
    Eickmeier, Olaf
    Pisi, Giovanna
    Fainardi, Valentina
    Zielen, Stefan
    Esposito, Susanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [4] Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
    Cohen-Cymberknoh, Malena
    Reiss, Bar Gindi
    Reiter, Joel
    Lechtzin, Noah
    Melo, Joel
    Perez, Gema
    Blau, Hannah
    Mussaffi, Huda
    Levine, Hagit
    Bentur, Lea
    Gur, Michal
    Livnat, Galit
    Perez Miranda, Javier
    Polverino, Eva
    Blasi, Francesco
    Aliberti, Stefano
    Aviram, Micha
    Tripto, Inbal Golan
    Picard, Elie
    Novoselsky, Michal
    Amsalem, Hagai
    Celnikier, Drorith Hochner
    Kerem, Eitan
    Shteinberg, Michal
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (03) : 388 - 394
  • [5] Elucidating progression of early cystic fibrosis lung disease
    Ramsey, Kathryn
    Ratjen, Felix
    Latzin, Philipp
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [6] Early infection and progression of cystic fibrosis lung disease
    Koch, C
    PEDIATRIC PULMONOLOGY, 2002, 34 (03) : 232 - 236
  • [7] Progression of Lung Disease in Preschool Patients with Cystic Fibrosis
    Stanojevic, Sanja
    Davis, Stephanie D.
    Retsch-Bogart, George
    Webster, Hailey
    Davis, Miriam
    Johnson, Robin C.
    Jensen, Renee
    Ester Pizarro, Maria
    Kane, Mica
    Clem, Charles C.
    Schornick, Leah
    Subbarao, Padmaja
    Ratjen, Felix A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1216 - 1225
  • [8] Stemming Early Progression of Airways Disease in Cystic Fibrosis
    Boat, Thomas F.
    JOURNAL OF PEDIATRICS, 2014, 165 (06): : 1078 - 1079
  • [9] DISEASE PROGRESSION IN CYSTIC FIBROSIS - SYNTHESIS OF SURVIVAL EVIDENCE
    Becker, C. C.
    Vieira, M. C.
    Harrow, B.
    Liou, T. G.
    Jansen, J. P.
    VALUE IN HEALTH, 2011, 14 (03) : A138 - A138
  • [10] Dornase alfa and progression of lung disease in cystic fibrosis
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2008, 43 (09) : S24 - S28